ID28811A - Antagonis reseptor vitronektin - Google Patents

Antagonis reseptor vitronektin

Info

Publication number
ID28811A
ID28811A IDW00200101183A ID20011183A ID28811A ID 28811 A ID28811 A ID 28811A ID W00200101183 A IDW00200101183 A ID W00200101183A ID 20011183 A ID20011183 A ID 20011183A ID 28811 A ID28811 A ID 28811A
Authority
ID
Indonesia
Prior art keywords
vitronektin
receptor antagonists
antagonists
receptor
vitronektin receptor
Prior art date
Application number
IDW00200101183A
Other languages
English (en)
Indonesian (id)
Inventor
William H Miller
Peter J Manley
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ID28811A publication Critical patent/ID28811A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
IDW00200101183A 1998-12-04 1999-12-03 Antagonis reseptor vitronektin ID28811A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11090398P 1998-12-04 1998-12-04

Publications (1)

Publication Number Publication Date
ID28811A true ID28811A (id) 2001-07-05

Family

ID=22335565

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101183A ID28811A (id) 1998-12-04 1999-12-03 Antagonis reseptor vitronektin

Country Status (39)

Country Link
US (1) US6495560B1 (fr)
EP (1) EP1146874B1 (fr)
JP (1) JP4481504B2 (fr)
KR (1) KR100620485B1 (fr)
CN (1) CN1147300C (fr)
AP (1) AP1534A (fr)
AR (1) AR035006A1 (fr)
AT (1) ATE277043T1 (fr)
AU (1) AU754408B2 (fr)
BG (1) BG65118B1 (fr)
BR (1) BR9915879A (fr)
CA (1) CA2353415A1 (fr)
CO (1) CO5150166A1 (fr)
CZ (1) CZ20011963A3 (fr)
DE (1) DE69920518T2 (fr)
DK (1) DK1146874T3 (fr)
DZ (1) DZ2954A1 (fr)
EA (1) EA003254B1 (fr)
EG (1) EG24025A (fr)
ES (1) ES2229798T3 (fr)
HK (1) HK1042037B (fr)
HU (1) HUP0104804A3 (fr)
ID (1) ID28811A (fr)
IL (2) IL143390A0 (fr)
MA (1) MA25265A1 (fr)
NO (1) NO318895B1 (fr)
NZ (1) NZ511876A (fr)
OA (1) OA11724A (fr)
PE (1) PE20001563A1 (fr)
PL (1) PL195973B1 (fr)
PT (1) PT1146874E (fr)
SI (1) SI1146874T1 (fr)
SK (1) SK7452001A3 (fr)
TR (1) TR200101654T2 (fr)
TW (1) TW482673B (fr)
UA (1) UA71586C2 (fr)
UY (1) UY25824A1 (fr)
WO (1) WO2000033838A1 (fr)
ZA (1) ZA200104398B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY26780A1 (es) * 2000-06-15 2002-01-31 Pharmacia Corp Cicloalquil avb3 antagonistas
ES2259047T3 (es) * 2000-10-24 2006-09-16 MERCK & CO., INC. Antagonista de receptor de integrina de la dibenzoxazepina.
US6855722B2 (en) 2001-01-29 2005-02-15 Dimensional Pharmaceuticals, Inc. Substituted indoles and their use as integrin antagonists
US6872730B2 (en) 2001-04-27 2005-03-29 3-Dimensional Pharmaceuticals, Inc. Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
US20040224986A1 (en) 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
CA2510084A1 (fr) 2002-12-20 2004-07-15 Pharmacia Corporation Composes de thiazole en tant que derives d'antagonistes des recepteurs de l'integrine
GB0319069D0 (en) * 2003-08-14 2003-09-17 Glaxo Group Ltd Therapeutically useful compounds
TW200635902A (en) * 2004-12-21 2006-10-16 Smithkline Beecham Corp Methods and formulations
KR101491938B1 (ko) 2010-07-14 2015-02-10 노파르티스 아게 Ｉｐ 수용체 효능제 헤테로시클릭 화합물
US8937069B2 (en) 2012-01-13 2015-01-20 Novartis Ag Substituted pyrrolo[2,3-B]pyrazine compounds and their use
EP2956455B1 (fr) 2013-02-13 2017-05-17 Novartis AG Composes heterocycliques a activite agoniste sur le recepteur ip
PL3050878T3 (pl) 2013-09-24 2022-01-24 Fujifilm Corporation Zawierający atom azotu związek lub jego sól, lub ich kompleks z metalem

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687154B1 (fr) 1992-02-07 1995-05-12 Rhone Poulenc Rorer Sa Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent.
PT910563E (pt) * 1995-06-29 2003-09-30 Smithkline Beecham Corp Antagonistas de receptores de integrina
AU4109297A (en) * 1996-09-27 1998-04-17 Merkler, H. Tank for liquids, particularly for chemically aggressive liquids
EP0946180A4 (fr) 1996-10-07 2003-07-23 Smithkline Beecham Corp Procede de stimulation de la formation osseuse
UY24949A1 (es) * 1997-04-08 2001-04-30 Smithkline Beecham Corp Compuestos calcilíticos

Also Published As

Publication number Publication date
KR20010080669A (ko) 2001-08-22
NO20012732D0 (no) 2001-06-01
AR035006A1 (es) 2004-04-14
PE20001563A1 (es) 2001-02-09
HK1042037B (zh) 2005-07-29
MA25265A1 (fr) 2001-10-01
HUP0104804A2 (hu) 2002-05-29
EA003254B1 (ru) 2003-02-27
AU754408B2 (en) 2002-11-14
DE69920518T2 (de) 2005-09-22
DZ2954A1 (fr) 2004-06-20
NO20012732L (no) 2001-08-01
EG24025A (en) 2008-03-26
CN1334730A (zh) 2002-02-06
SK7452001A3 (en) 2001-12-03
DE69920518D1 (de) 2004-10-28
PL195973B1 (pl) 2007-11-30
PL348702A1 (en) 2002-06-03
EP1146874A1 (fr) 2001-10-24
CN1147300C (zh) 2004-04-28
DK1146874T3 (da) 2005-01-31
SI1146874T1 (en) 2005-04-30
PT1146874E (pt) 2005-02-28
OA11724A (en) 2005-01-26
UA71586C2 (en) 2004-12-15
TW482673B (en) 2002-04-11
NZ511876A (en) 2004-02-27
CA2353415A1 (fr) 2000-06-15
IL143390A0 (en) 2002-04-21
AU1750200A (en) 2000-06-26
CO5150166A1 (es) 2002-04-29
WO2000033838A1 (fr) 2000-06-15
EP1146874B1 (fr) 2004-09-22
AP1534A (en) 2006-01-09
UY25824A1 (es) 2001-07-31
JP4481504B2 (ja) 2010-06-16
IL143390A (en) 2006-07-05
ATE277043T1 (de) 2004-10-15
JP2003523931A (ja) 2003-08-12
HUP0104804A3 (en) 2002-12-28
BG105651A (en) 2002-02-28
US6495560B1 (en) 2002-12-17
CZ20011963A3 (cs) 2001-11-14
EA200100618A1 (ru) 2001-12-24
ES2229798T3 (es) 2005-04-16
NO318895B1 (no) 2005-05-18
ZA200104398B (en) 2002-05-29
BR9915879A (pt) 2002-02-13
EP1146874A4 (fr) 2002-06-05
KR100620485B1 (ko) 2006-09-13
BG65118B1 (bg) 2007-03-30
HK1042037A1 (en) 2002-08-02
TR200101654T2 (tr) 2002-03-21

Similar Documents

Publication Publication Date Title
ID19623A (id) Antagonis reseptor vitronektin
DE69812096D1 (de) Neuropeptid y rezeptorantagonisten
ATE280157T1 (de) 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
NO20012411D0 (no) Pyrrolidin-derivater-CCR-3-reseptorantagonister
IS5706A (is) Adenosín A3 viðtakastillar
DK1009732T3 (da) 1-Amino-alkylcyclohexan NMDA receptor antagonister
DE69905248T2 (de) Neuropeptid y5-rezeptorantagonisten
ID18003A (id) Antagonis muskarinik
ID16742A (id) Antagonis reseptor endotelin
NO993586L (no) K-8 reseptor antagonister
ID26223A (id) Antagonis reseptor vitronektin
DE69919171D1 (de) Muskarin-rezeptor antagonisten
ID24726A (id) Antagonis-antagonis reseptor trombin
ID24162A (id) Antagonis-antagonis reseptor vitronektin
NO20015779L (no) Bradykinin-reseptorantagonister
ID26665A (id) Antagonis vla-4
ID28811A (id) Antagonis reseptor vitronektin
ID22838A (id) Oksazolidina sebagai antagonis 5-ht2a
ATE381330T1 (de) Il-8 rezeptor-antagonisten
ID24468A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ID27845A (id) Turunan tetrahidrokuilina sebagai antagonis glisilina
TR199501389A2 (tr) Adesyon reseptörü antagonistleri (karsitlari).
DE69831413D1 (de) Il-8 rezeptor antagonisten
DE69824837D1 (de) Il-8-rezeptor-antagonisten
ID24309A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin